Conclusion
upper gastrointestinal endoscopy
ADVERSE EVENTS
Co-administration of remimazolam tosylate and propofol could reduce adverse events in upper gastrointestinal endoscopy, the success rate of sedation was the same with propofol, and had higher endoscopist satisfaction than remimazolam monotherapy, suggesting that the combination of the two drugs is feasible and may have greater clinical value in outpatient examinations.